Research Library — Page 7 | Reta Compare
402 research articles. Page 7 of 17.
Articles
- Exploring Retatrutide: A Multifunctional Incretin Peptide in Diabetes and Obesity Management
- Exploring the Role of Retatrutide in Treating Psychiatric Conditions
- Retatrutide's Role in Cardiovascular Health for Obese Individuals: Insights from Recent Meta-Analysis
- Exploring Retatrutide's Role in Obesity and Cardiovascular Health
- Evaluating Retatrutide in the Context of Comparative Weight Loss Pharmacotherapy
- Examining Sex Differences in Weight Loss Efficacy of Retatrutide and Other GLP-1RAs
- Exploring Retatrutide: Insights from GLP-1RA and Its Role in Obesity Treatment
- Exploring the Efficacy of Retatrutide in Weight Reduction Compared to Other GLP-1 Receptor Agonists
- Retatrutide's Role in Overcoming Therapeutic Barriers in Obese TNBC
- Exploring Retatrutide: A New Triple Agonist in Obesity Treatment
- Retatrutide: A Promising Triple Hormone Receptor Agonist for Obesity Management
- Retatrutide: Efficacy and Safety in Weight Loss Among Adults Without Diabetes
- Exploring Retatrutide's Role in the Evolving Landscape of Obesity Treatment
- Exploring Retatrutide: A Triple Agonist for Obesity and Type 2 Diabetes Management
- Exploring the Role of Retatrutide in Obesity Management and Comorbidities
- Retatrutide: Efficacy and Safety in Obesity Treatment Explored
- Retatrutide's Role in Reducing Obesity-Associated Cancer Progression
- Retatrutide's Role in Weight Management and Glycemic Control: Insights from Recent Research
- Retatrutide: Insights from Emerging Pharmacotherapies for Obesity Management
- Exploring the Role of Retatrutide in the Compounded GLP-1 Market for Weight Loss
- Retatrutide: Advancements in Unimolecular Polypharmacology for Weight Loss
- Evaluating the Efficacy of Retatrutide in Diabetic Kidney Disease Compared to Liraglutide and Tirzepatide
- Retatrutide: A Triple Agonist in the Management of Obesity and Type 2 Diabetes
- Exploring Retatrutide: The Future of Anti-Obesity Medications
- Exploring Retatrutide: A Novel Triagonist for Obesity Management